Tim Demuth - Net Worth and Insider Trading
Tim Demuth Net Worth
The estimated net worth of Tim Demuth is at least $758 dollars as of 2024-06-11. Tim Demuth is the Chief Medical Officer of Pieris Pharmaceuticals Inc and owns about 75 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $758. Details can be seen in Tim Demuth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tim Demuth has not made any transactions after 2022-05-13 and currently still holds the listed stock(s).
Transaction Summary of Tim Demuth
Tim Demuth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tim Demuth owns 1 companies in total, including Pieris Pharmaceuticals Inc (PIRS) .
Click here to see the complete history of Tim Demuth’s form 4 insider trades.
Insider Ownership Summary of Tim Demuth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2022-05-13 | Chief Medical Officer |
Tim Demuth Latest Holdings Summary
Tim Demuth currently owns a total of 1 stock. Tim Demuth owns 75 shares of Pieris Pharmaceuticals Inc (PIRS) as of May 13, 2022, with a value of $758.
Latest Holdings of Tim Demuth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2022-05-13 | 75 | 10.10 | 758 |
Holding Weightings of Tim Demuth
Tim Demuth Form 4 Trading Tracker
According to the SEC Form 4 filings, Tim Demuth has made a total of 1 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pieris Pharmaceuticals Inc is the acquisition of 75 shares on May 13, 2022, which cost Tim Demuth around $10,260.
Insider Trading History of Tim Demuth
- 1
Tim Demuth Trading Performance
GuruFocus tracks the stock performance after each of Tim Demuth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tim Demuth is -8.19%. GuruFocus also compares Tim Demuth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tim Demuth within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tim Demuth's insider trading performs compared to the benchmark.
Performance of Tim Demuth
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.51 | | | | | |
| Relative Return to S&P 500(%) | 3.31 | | | | | |
Tim Demuth Ownership Network
Tim Demuth Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Tim Demuth is the Chief Medical Officer of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Tim Demuth made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 10,000 shares made by Christopher P Kiritsy ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 125 shares were bought by its insiders, resulting in a net purchase of 125 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Tim Demuth Mailing Address
Above is the net worth, insider trading, and ownership report for Tim Demuth. You might contact Tim Demuth via mailing address: C/o Pieris Pharmaceuticals, Inc., 255 State Street, 9th Floor, Boston Ma 02109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
